Intellia presents Phase 3 results for HAE gene therapy lonvo-z

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Entera Bio presents Phase 1 data on single-tablet EB613 Hisse Senetleri 0 10
A Crinetics presents phase 2 data for CAH treatment atumelnant Hisse Senetleri 0 4
A Upstream Bio presents positive Phase 2 trial data for verekitug Hisse Senetleri 0 4
A Agios presents detailed mitapivat trial results for sickle cell Hisse Senetleri 0 8
A Disc Medicine presents trial data for blood disorder treatments Hisse Senetleri 0 9
A Cathie Wood’s ARK sells AMD stock, buys Roblox and Intellia Hisse Senetleri 0 31
A BofA raises Intellia Therapeutics price target on FDA hold lift Hisse Senetleri 0 24
A Cathie Wood’s ARK adds to Intellia stock holdings on January 15 Hisse Senetleri 0 57

Benzer konular

Üst